Droloxifene
Droloxifene (3-Hydroxytamoxifen) is an orally active SERM derived from tamoxifen. It induces p53 expression and apoptosis in MCF-7 breast cancer cells in vitro and has demonstrated bone-protective effects in ovariectomized rat models in vivo.
Product Specifications
CAS Number
82413-20-5
Product Name Alternative
Estrogen receptor, Estrogen Receptor, EstrogenReceptor, ERR, 3-Hydroxytamoxifen, Droloxifene
Field of Research
Cell Biology, Metabolism Research
Purity
99.27% (May vary between batches)
Solubility
DMSO:40 mg/mL (103.22 mM) ;10% DMSO+90% Corn Oil:4 mg/mL (10.32 mM)
Smiles
CC\C (=C (\c1ccc (OCCN (C) C) cc1) c1cccc (O) c1) c1ccccc1
Molecular Formula
C26H29NO2
Molecular Weight
387.51
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6004116-01 0.2 mL
GPRC5B, CT (GPRC5B, RAIG2, G-protein coupled receptor family C group 5 member B, A-69G12.1, Retinoic acid-induced gene 2 protein)
Sign In for Pricing
View Details MBS6004116-02 5x 0.2 mL
GPRC5B, CT (GPRC5B, RAIG2, G-protein coupled receptor family C group 5 member B, A-69G12.1, Retinoic acid-induced gene 2 protein)
Sign In for Pricing
View Details 
ARP63464_P050-HRP 100 µL
VILL Antibody - C-terminal region : HRP (ARP63464_P050-HRP)
Sign In for Pricing
View Details